Story · Medicine & Biotech

Harshabad Singh: Daraxonrasib EAP Marks a Meaningful Milestone for Patients With Pancreatic Cancer

1 outlet · first reported by OncoDaily 11h ago

Coverage, in order

  1. 11h ago
    OncoDaily obscure
    Harshabad Singh: Daraxonrasib EAP Marks a Meaningful Milestone for Patients With Pancreatic Cancer

    Harshabad Singh, Program Director Hepatobiliary and Pancreas Cancers at Mass general Brigham, shared on LinkedIn: “Tonight we celebrated the successful completion of Daraxonrasib expanded access program (EAP) at Mass General

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.